Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

4D MOLECULAR THERAPEUTICS, INC.

(FDMT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about 4D MOLECULAR THERAPEUTICS, INC.
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of 2021 and P..
PU
08/124D MOLECULAR THERAPEUTICS : Earnings Flash (FDMT) 4D MOLECULAR THERAPEUTICS Reports Q2 Rev..
MT
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of 2021 and P..
AQ
08/124D Molecular Therapeutics, Inc. Appoints Nadine Greiner as Chief Human Resources Office..
CI
08/124D Molecular Therapeutics, Inc. Announces Unaudited Earnings Results for the Second Qua..
CI
06/254D Molecular Therapeutics, Inc. Announces Rare Disease Ophthalmology Product Candidate ..
CI
06/254D-110 : Initial clinical safety data at both of the two dose levels in the Phase 1 clinic..
PU
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Growth Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Microcap Growth Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Microcap Value Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Value Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell 3000E Index
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Microcap Index
CI
06/244D MOLECULAR THERAPEUTICS : Says Roche Stops Trial, Cancels Licensing Deal for Eye Drug; S..
MT
06/244D Molecular Shares Hit 52-Week Low After Roche Ends Collaboration Agreement
DJ
More most relevant news
All news about 4D MOLECULAR THERAPEUTICS, INC.
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of 2021 and P..
PU
08/124D MOLECULAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition an..
AQ
08/124D MOLECULAR THERAPEUTICS INC. : Results of Operations and Financial Condition, Financial ..
AQ
08/124D MOLECULAR THERAPEUTICS : Earnings Flash (FDMT) 4D MOLECULAR THERAPEUTICS Reports Q2 Rev..
MT
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of 2021 and P..
AQ
08/124D Molecular Therapeutics, Inc. Appoints Nadine Greiner as Chief Human Resources Office..
CI
08/124D Molecular Therapeutics, Inc. Announces Unaudited Earnings Results for the Second Qua..
CI
06/254D MOLECULAR THERAPEUTICS INC. : Termination of a Material Definitive Agreement, Other Eve..
AQ
06/254D Molecular Therapeutics, Inc. Announces Rare Disease Ophthalmology Product Candidate ..
CI
06/254D MOLECULAR THERAPEUTICS, INC.(NASD : FDMT) added to Russell Microcap Growth Index
CI
More news
News in other languages on 4D MOLECULAR THERAPEUTICS, INC.

- No features available -

More news
Analyst Recommendations on 4D MOLECULAR THERAPEUTICS, INC.
01/054D MOLECULAR THERAPEUTICS : BofA Securities Starts 4D Molecular Therapeutics at Buy With $..
MT
01/054D MOLECULAR THERAPEUTICS : Evercore ISI Starts 4D Molecular Therapeutics at Outperform Wi..
MT
01/054D MOLECULAR THERAPEUTICS : Goldman Sachs Starts 4D Molecular Therapeutics at Neutral With..
MT
More recommendations
Press releases
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of 2021 and P..
PU
08/124D MOLECULAR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition an..
AQ
08/124D MOLECULAR THERAPEUTICS INC. : Results of Operations and Financial Condition, Financial ..
AQ
08/124D MOLECULAR THERAPEUTICS : Reports Financial Results for the Second Quarter of 2021 and P..
AQ
06/254D MOLECULAR THERAPEUTICS INC. : Termination of a Material Definitive Agreement, Other Eve..
AQ
More press releases